1Garofolo F, Michon J,Leclaire V,et al. US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical Consortium[J]. Bioanalysis, 2012,4(3): 231.
2Kelley M, DeSilva B. Key elements of bioanalytical method validation for macromolecules [J]. AAPS J,2007, 9(2): E156.
3Viswanathan CT, Bansal S,Booth B,et al. Quantitative bioanalytical methods validation and implementation: bestpractices for chromatographic and ligand binding assays[J]. Pharm Res,2007,24(10): 1962.
4Savoie N, Garofolo F, van Amsterdam P,et al. 2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance [J]. Bioanalysis,2010, 2(12): 1945.
5Smolec J,DeSilva B, Smith W, et al. Bioanalytical method validation for macromolecules in support of pharmacokinetic studies[J]. Pharm Res, 2005,22(9): 1425.
6Viswanathan CT, Bansal S, Booth B, et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays[J]. Pharm Res,2007,24(10): 1962.
7DeSilva B, Smith W, Weiner R,et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules[J]. Pharm Res, 2003, 20(11): 1885.
8Findlay JW, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective[J]. J Pharm Biomed Anal, 2000, 21(6): 1249.
9Timmerman P, Luedtke S, van Amsterdam P, et al. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum [J]. Bioanalysis, 2009, 1(6): 1049.
10Rocci ML Jr, Devanarayan V,Haughey DB, et al. Confirmatory reanalysis of incurred bioanalytical samples[J]. AAPS J, 2007, 9(3): E336.
